Page 11 - Pfizer

Pfizer working on updated jab in response to Omicron variant: CEO

Pfizer's chief executive Dr Albert Bourla said he is of the view that annual vaccinations would be needed to maintain a "very high level of protection" against the deadly disease

Pfizer begins application for Canada's approval of Covid-19 pill

The country has identified seven people with the new variant as of Nov. 30.

Pfizer, BioNTech unsure of vax effectiveness against new Covid variant

The companies also promised to develop a new vaccine against the variant in about 100 days

LIVE: 25 killed, 17 missing as flash floods ravage Andhra Pradesh

In Kadiri town in Anantapuramu district, a building under construction collapsed due to incessant rain and fell on an adjoining one, killing at least five persons, including two children

Canada to allow entry to those vaccinated with Sinopharm, Sinovac, Covaxin

Currently, Canada only accepts travellers who have received the vaccines, including Pfizer, Moderna, AstraZeneca and Johnson and Johnson

FDA authorises Pfizer, Moderna Covid-19 vaccine boosters for US adults

The regulator's decision paves the way for millions of Americans to get additional protection

Pfizer signs $5.3-bn deal with US govt for 10 mn Covid-19 pills

The oral drug could be a promising new weapon in the fight against the pandemic

FDA plans to authorise Pfizer boosters for adults this week: Report

The Food and Drug Administration is aiming to authorise booster doses of Pfizer-BioNTech's coronavirus vaccine for all adults as early as Thursday

Stocks to Watch: IndiGo, Biocon, Pfizer, IEX, TFCI, SAIL, BHEL, Nalco

Indian Energy Exchange and Apollo Pipes have announced their respective record dates for the issuance of bonus shares for eligible shareholders

Pfizer to allow generic versions of its Covid-19 pill in 95 countries

The voluntary licensing agreement between Pfizer and the MPP will allow the United Nations-backed group to grant sub-licenses to qualified generic drug manufacturers

Pfizer's anti-Covid pill can be made by Indian drug firms without royalties

Pharma major will waive royalties on sales in all countries covered by the MPP agreement apart from poor nations

Multiple near-term concerns trigger Divi's Laboratories' headache

Pfizer's oral Covid drug, weak sales of generics, and valuations may cap upsides

Pfizer agrees to let other companies make its Covid-19 pill

The move could make the treatment available to more than half of the world's population

Pfizer fights to control secret of $36-billion Covid-19 jab recipe

Pfizer has begun to ramp up vaccine deliveries quickly outside the richest nations

Pfizer, Astra shots generate more antibodies than natural infection: Study

People who receive the Pfizer or AstraZeneca COVID-19 vaccine have antibody levels significantly higher than those infected with the SARS-CoV-2 virus, according to a study

Pfizer's oral Covid-19 drug may hit revenues of Divi's Laboratories

Supply of Molnupiravir to Merck was a key near-term trigger for the stock

S&P 500 hits record on strong jobs report, Pfizer Covid-19 pill cheer

US job growth regains momentum Pfizer jumps after positive Covid-19 antiviral pill data

Pfizer develops Covid pill that cuts hospitalisations and deaths by 89%

A pill that could be taken at home at the first sign of symptoms is a crucial tool for taming the Covid-19 crisis globally, so long as it's widely available

Wall St extends record rally on strong jobs report, Pfizer Covid pill cheer

October payrolls surge back as virus impact fades; travel stocks lead broader market gains

Top headlines: Pfizer's pill cuts risk of severe Covid; Delhi AQI worsens

Business Standard brings you the top headlines on Friday